doi: 10.1016/j.cmet.2016.11.004 22 HandelsmanD
Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.01 - REHABILITATION P259 - ESOC25-1483 A SYSTEMATIC REVIEW OF THE PHARMACOLOGICAL INTERVENTIONS FOR POST STROKE COGNITIVE IMPAIRMENT Sara Fakhraie 1 , Aynaz Hatami 2 , Armin Jabraili 3 , Nadia Doostar 4 , Hanie Karimi 5 , Hesam Shahabifard 6 , Ramin Ahangar-Sirous 7 , Mojtaba Azari 8 , Morteza Azari 8,9 , Reza Mosaddeghi 10 , Saeed Sadigh-Eteghad 1 , Amirreza Naseri 2 1 Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran, 2 Faculty of medicine, Tabriz University of medical sciences, Tabriz, Iran, 3 Faculty of Medicine, Islamic Azad University of Ardabil, Ardabil, Iran, Ardabil, Iran, 4 Faculty of Medicine, Ardabil University of medical sciences, Ardabil, Iran, Ardabil, Iran, 5 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, 6 Neurosciences Research Center,Tabriz University of medical sciences,Tabriz,ran Orcid : 0000000206758483, Tabriz, Iran, 7 Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran Tabriz, Iran, 8 1
The TB-500 component (thymosin -4) is a prohibited substance under WADA Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times
Turn right
Clinical research has directly compared the two and liposomal form consistently shows higher increases in blood glutathione levels
Similarly, the comparison between asymptomatic V30M carriers and healthy controls did not reach statistical significance in the two-tailed analysis ( p = 0.0954
